‌

US Patent 11407825 NaPi2b-targeted polymer antibody-drug conjugates and methods of use thereof

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Patent Applicant

Mersana Therapeutics

Current Assignee

Mersana Therapeutics

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

11407825

Date of Patent

August 9, 2022

Patent Application Number

16542642

Date Filed

August 16, 2019

Patent Citations

‌

US Patent 10947317 NaPi2b-targeted antibody-drug conjugates and methods of use thereof

Patent Primary Examiner

CPC Code

...

Disclose herein are dosing regimens for targeted NaPi2b antibody-drug conjugates for treating cancer.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11407825 NaPi2b-targeted polymer antibody-drug conjugates and methods of use thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API